Journal article
Primary Prevention of Cardiovascular Mortality and Events With Statin Treatments A Network Meta-Analysis Involving More Than 65,000 Patients
Abstract
OBJECTIVES: This study aimed to evaluate the effectiveness of 3-hydroxy-3-methyl-glutaryl-CoA reductase inhibitors (statins) in primary prevention of cardiovascular events.
BACKGROUND: The role of statins is well established for secondary prevention of cardiovascular disease (CVD) clinical events and mortality. Little is known of their role in primary cardiovascular event prevention.
Authors
Mills EJ; Rachlis B; Wu P; Devereaux PJ; Arora P; Perri D
Journal
Journal of the American College of Cardiology, Vol. 52, No. 22, pp. 1769–1781
Publisher
Elsevier
Publication Date
November 2008
DOI
10.1016/j.jacc.2008.08.039
ISSN
0735-1097